By Serena Gordon HealthDay Reporter WEDNESDAY, April 12, 2017 (HealthDay News) -- Two new studies on diabetes deliver good and bad news, but the overall message is that the blood sugar disease remains a formidable public health burden. Click here to read the entire article.
GlycoMark, Inc. announced it has named longtime GlycoMark executive Hirotaka “Hiro” Ishibashi as Chief Operating Officer (COO). GlycoMark is a company created in 2008 to introduce an innovative diagnostic test for intermediate-term monitoring of glycemic control in people with diabetes. Ishibashi previously served as Director of International Business Development before... read more →
Measuring Incidence of Hyperglycemia May Be Key to Avoiding Long-Term Health Risks New York, NY (December 6, 2016) — Nearly 30 million people in the United States suffer from the epidemic of diabetes. However, nearly 40% of diabetes patients in “good control” have persistently elevated glucose levels (hyperglycemia) and significant... read more →
Diazyme Panel Features Glycomark®—The Only Blood Test that Specifically Indicates Recent Hyperglycemia Philadelphia, PA—GlycoMark, Inc. announced it has partnered with Diazyme Laboratories to offer the first diabetes panel to test three different ç (Diazyme’s Glycated Serum Protein/GSP and Enzymatic HbA1c) along with GlycoMark—a test specifically related to hyperglycemia over a... read more →
From healio.com.... Small, achievable and sustained improvements in HbA1c across the diabetes population in the United Kingdom can reduce the number of complications and the economic costs of dealing with them, according to recent study results. The findings, according to researchers, are not predicated on any specific therapy, but rather more... read more →
Dr. Damon Tanton, Medical Director of Clinical Practice for the Florida Hospital Diabetes Institute and Florida Diabetes and Endocrine Center, explains insulin resistance and the importance of early diagnosis and treatment. Do you have difficulty losing abdominal fat? Do you crave sweets and carbohydrates on a daily basis? Do you feel... read more →
NEW YORK, NY (October 23, 2015) – In a new study published by the medical journal Diabetes involving more than 11,000 subjects, the GlycoMark® test was used to help define links between hyperglycemic excursions and increased incidence of cardiovascular disease and death1. The recently published study involved analysis from the... read more →
Upcoming webinar by the American Association for Clinical Chemistry (AACC) warns of variants and adducts that may affect accuracy of A1C tests New York, NY (October 15, 2015) – An upcoming webinar hosted by the AACC will discuss potential pitfalls of the hemoglobin A1C test due to conditional interferences that... read more →